ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 932

Hypoxia and Signal Transducer and Activator Of Transcription 3 Signalling Interactions Regulate Pro-Inflammatory Pathways In Rheumatoid Arthritis

Wei Gao1, Jennifer McCormick1, Mary Connolly2, Emese Balogh2, Douglas J. Veale1 and Ursula Fearon1, 1Dublin Academic Medical Centre, Translational Rheumatology Research Group, Dublin, Ireland, 2Rheumatology, Translation Research Group, Dublin Academic Medical Centre, St. Vincent's University Hospital, Dublin, Ireland

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Angiogenesis, cytokines and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Cytokines, Mediators, Cell-cell Adhesion, Cell Trafficking and Angiogenesis I

Session Type: Abstract Submissions (ACR)

Background/Purpose: Signal Transducer and Activator of Transcription 3 (STAT3), a critical transcription activator in angiogenesis, plays a crucial role in the pathogenesis of Rheumatoid Arthritis (RA). Hypoxia and Notch signalling regulate angiogenesis, cell proliferation, invasion and survival. This study was to examine the effect of hypoxia on STAT3-induced pro-inflammatory pathways in RA.

Methods: Expression of phospho-STAT3 in synovial tissue and RA synovial fibroblasts (RASFC) was assessed by immunohistology/immunofluorescence. Primary RASFC and synoviocyte cell lines (K4IM) were cultured under 3% hypoxia and normoxia conditions±Stat3-siRNA, HIF-siRNA or WP1066 (potent STAT inhibitor). HIF1α, p-STAT3 and Notch-1IC (intracellular domain) protein expression were analyzed by Western blot. Functional mechanisms were quantified by invasion chamber, matrigel and wound repair assays. IL-6, IL-8, IL-10 and MMP-3 were quantified by ELISA. Notch-1 receptor, its DLL-4 ligand and downstream target genes (hrt-1, hrt-2) were quantified by Real-time PCR. Finally the effect of WP1066 on spontaneous secretion of pro/anti-inflammatory cytokines was examined in RA synovial explants ex-vivo.

Results: Increased p–STAT3 expression was demonstrated in RA synovium compared to healthy control (p<0.05) and 3% hypoxia induced nuclear translocation of p-STAT3 in RASFC. Hypoxia induced p-STAT3 and HIF1α expression, an effect blocked by Stat3-siRNA and WP1066. Hypoxia-induced cell invasion, migration and cytokine production were inhibited by Stat3-siRNA (all p<0.05) and WP1066 (all p<0.05). While HIF1α siRNA inhibited hypoxia-induced p-STAT3 expression, Stat3-siRNA also inhibited hypoxia-induced HIF1α. Furthermore hypoxia-induced Notch-1IC, DLL4, hrt-1 and -2 expression were significantly inhibited by STAT3 blockade (p<0.05). Finally, in RA synovial explant cultures ex-vivo, STAT3 blockade decreased spontaneous secretion of IL-6, IL-8 and MMP3 (p<0.05), and induced IL-10 (p<0.05).

Conclusion: This is the first study to provide evidence of a functional link between HIF1α, STAT3 and Notch-1 signalling in the regulation of pro-inflammatory mechanisms in RA, and further supports a role for STAT blockade in the treatment of RA.


Disclosure:

W. Gao,
None;

J. McCormick,
None;

M. Connolly,
None;

E. Balogh,
None;

D. J. Veale,

AbbVie, ,

2,

Pfizer Inc,

2,

MSD,

2,

Roche Pharmaceuticals,

2,

Pfizer Inc,

5,

Roche Pharmaceuticals,

5,

Abbott Laboratories,

8,

Pfizer Inc,

8,

MSD,

8,

Roche Pharmaceuticals,

8;

U. Fearon,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/hypoxia-and-signal-transducer-and-activator-of-transcription-3-signalling-interactions-regulate-pro-inflammatory-pathways-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology